Evidence map›Paper›PMID 25667215›Full record

ArticleThe Annals of otology, rhinology, and laryngology2015

Dexamethasone Controlled Release on TGF-β1 Treated Vocal Fold Fibroblasts.

Aaron M Kosinski, Jewel M Pothen, Alyssa Panitch, M Preeti Sivasankar

Open access · greenAbstract read
In one paragraph

Article in The Annals of otology, rhinology, and laryngology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Towards an in vitro fibrogenesis model of human vocal fold scarring.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2018
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Aaron M KosinskiWeldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana, USA.
Jewel M PothenWeldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana, USA.
Alyssa PanitchWeldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana, USA.
M Preeti SivasankarSpeech, Language, and Hearing Sciences, Purdue University, West Lafayette, Indiana, USA msivasankar@purdue.edu.
Purdue University West Lafayette · US

Funding

Fluid Structure Interactions Within the Human LarynxR01DC005788 · NIDCD · PURDUE UNIVERSITY WEST LAFAYETTE · PI MONGEAU, LUC · 2003 to 2018
$6.4M
Challenges to Vocal Fold Epithelia: Functional and Structural ConsequencesR01DC011759 · NIDCD · PURDUE UNIVERSITY · PI SIVASANKAR, PREETI M. · 2012 to 2016
$1.9M
Safety & effectiveness of HA hydrogels in immortalized vocal fold fibroblast cellR21DC008428 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI THIBEAULT, SUSAN L · 2006 to 2007
$399k
NIDCD NIH HHS R01 DC005788NIDCD NIH HHS R01DC005788NIDCD NIH HHS R01 DC011759NIDCD NIH HHS R01DC011759NIDCD NIH HHS R21 DC008428
6 · The paper itself

Abstract

objectiveCorticosteroids may be beneficial in treating vocal fold scarring. Current drug delivery methods do not permit controlled corticosteroid release. Here we investigate the effects of poly-lactic-co-glycolic acid (PLGA) microparticles loaded with the corticosteroid dexamethasone in reducing collagen synthesis and inflammation in vocal fold fibroblasts treated with and without TGF-β1. STUDY

designExperimental, in vitro study.

methodsPLGA microparticles of differing molecular weight and terminating moieties were synthesized using a hydrogel template method. The release of dexamethasone was characterized from these microparticles over 4 days. Based on the release studies, ester-terminated low molecular weight PLGA microparticles were loaded with dexamethasone and applied to TGF-β1 treated vocal fold fibroblasts for 4 days. Quantitative polymerase chain reaction (qPCR) and enzyme-linked immunosorbent assays (ELISAs) were used to assess the effects of released dexamethasone on collagen synthesis and inflammatory mediators.

resultsCOL3A1 and COL1A2 were significantly down-regulated after exposure to ester-terminated low molecular weight PLGA microparticles loaded with dexamethasone. The loaded microparticles also reduced interleukin-6 synthesis.

conclusionThese data show promise in using a PLGA microparticle-based delivery system to control dexamethasone release over 4 days. Our findings lay the groundwork for developing more effective treatments for vocal fold scarring.

Indexed as

Lactic AcidPolyglycolic AcidBiocompatible MaterialsCells, CulturedCicatrixCollagenCytokinesDelayed-Action PreparationsDexamethasoneDrug CarriersEnzyme-Linked Immunosorbent AssayFibroblastsGene Expression RegulationGlucocorticoidsHumansPolylactic Acid-Polyglycolic Acid CopolymerBiocompatible MaterialsCollagenCytokinesDelayed-Action PreparationsDexamethasoneDrug CarriersGlucocorticoidsLactic AcidPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerTransforming Growth Factor beta1dexamethasonedrug deliveryPLGA microparticlesvocal fold scar

Identifiers

PMID25667215
PMCPMC4717905
OpenAlexW2152400064

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.